tarcocimab

Kodiak's Eye Drug Revival Spurs Renewed FDA Approval Bid

Kodiak’s Eye Drug Revival Spurs Renewed FDA Approval Bid

Anika Sharma

Kodiak Sciences had previously abandoned its tarcocimab tedromer program following disappointing results in two phase 3 trials. However, a recent ...